MYOKARDIA
HQ - Brisbane
Summary
MyoKardia operates as a precision cardiovascular medicine company. The Company develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases. MyoKardia serves patients in the United States.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 10.01 B
Avg. Deal Size£ 10.01 B
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
